Article
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1.
Antimicrobial agents and chemotherapy - 1 Jun 2006
Balashov Sergey V, Park Steven, Perlin David S
Abstract excerpt
Resistance of clinical isolates of Candida albicans to the echinocandin drug caspofungin is slowly emerging and is linked to mutations in short conserved regions in the FKS1 gene. The most prominent changes occurred at the serine 645 position in Fks1p with substitutions of proline, tyrosine, and phenylalanine. An allele-specific real-time PCR molecular-beacon assay was developed for rapid identification of drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
